Eli Manning, Hall of Fame
Digest more
Eli Lilly is considering all these risks and planning accordingly, and doing so years in advance. That's also why the pharmaceutical giant has been making a push in oncology. And why it is building an artificial intelligence supercomputer that could help it develop medicines much faster and at lower costs.
24/7 Wall St. on MSN
Why Eli Lilly is the unexpected must-buy dividend powerhouse to own in 2026
Quick Read Eli Lilly (LLY) achieved 54% year-over-year revenue growth to $17.6B in Q3. Tirzepatide is projected as the top-selling drug by 2030. Lilly raised its quarterly dividend 15% to $1.73 per share.
Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than two months.
But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion in revenue. Wegovy generated approximately $9 billion -- despite having been approved in the U.S. more than two years before its competitor.
(Editor’s note: This story was written before Eli Manning was not included in the Pro Football Hall of Fame class of 2025.) Two guys are sitting in a bar. They could be talking about who the Giants’ next quarterback should be, or what went wrong with ...
Mizzou missed its offensive coordinator on Saturday night. A 13-7 loss to Virginia in the TaxSlayer Gator Bowl featured a hard-to-stomach offensive display from the Tigers, who closed out their season with a fifth loss in their final 8 games.
Ndiaye sustained a torn labrum in a G League game Dec. 9 and underwent season-ending surgery. The Hawks will put the young forward on waivers in order to clear up a two-way contract slot. Ndiaye didn't appear in an NBA game with the Hawks, and he's yet to make his NBA debut.
On Dec. 15, Sharabi spread light in Miami Beach during the American Friends of Magen David Adom Miami Gala held at the Miami Beach Convention Center.
Eli Manning has taken another step toward football immortality. The longtime New York Giants quarterback was named a finalist for the Pro Football Hall of Fame Class of 2026. Manning is one of 15 modern-era players still under consideration.